Exagen Inc expected to post a loss of 19 cents a share - Earnings Preview

Exagen

31/07/2026 13:35

Exagen Inc XGN.OQ XGN.O is expected to  show a rise in quarterly revenue when it reports  results on August 4 for the period ending June 30 2026
The Vista California-based  company is expected to report a 3.6% increase in revenue to $17.818 million from $17.2 million a year ago, according to the mean estimate from 8 analysts, based on LSEG data.
​LSEG's mean analyst estimate for Exagen Inc is for a loss of 19 cents per share. 
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 8 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."  
The mean earnings estimate of analysts was unchanged in the last three months. ​
Wall Street's median 12-month price target for Exagen Inc is $8.00, about 71.3% above its last closing price of $4.67
Previous quarterly performance (using preferred earnings measure in US dollars). ​
QUARTER ENDING
STARMINESMARTESTIMATE®
LSEG IBES ESTIMATE 
ACTUAL
BEAT, MET, MISSED
SURPRISE %
Mar. 31 2026
-0.23
-0.23
-0.20
Beat
14.3
Dec. 31 2026
-0.20
-0.19
-0.20
Missed
-5.3
Sep. 30 2025
-0.16
-0.16
-0.31
Missed
-96.8​
Jun. 30 2025
-0.15
-0.14
-0.18
Missed
-27.2
​​Mar. 31 2025
-0.20
-0.20
-0.20
Met
0.8
Dec. 31 2024
-0.26
-0.26
-0.20
Beat
23.1​
Sep. 30 2024
-0.29
-0.29
-0.28
Beat
3.4
Jun. 30 2024
-0.34
-0.34
-0.16
Beat
53.6
This summary was machine generated July 31 at 12:35 GMT.  All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)